Skip to content
← Back to this collection

PUBLICATIONS · 9469358

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1998 Feb
First author
Stewart S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Stewart S
      type
      Author
    2. name
      Jablonowski H
      type
      Author
    3. name
      Goebel FD
      type
      Author
    4. name
      Arasteh K
      type
      Author
    5. name
      Spittle M
      type
      Author
    6. name
      Rios A
      type
      Author
    7. name
      Aboulafia D
      type
      Author
    8. name
      Galleshaw J
      type
      Author
    9. name
      Dezube BJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Stewart S
      type
      Author
    2. name
      Jablonowski H
      type
      Author
    3. name
      Goebel FD
      type
      Author
    4. name
      Arasteh K
      type
      Author
    5. name
      Spittle M
      type
      Author
    6. name
      Rios A
      type
      Author
    7. name
      Aboulafia D
      type
      Author
    8. name
      Galleshaw J
      type
      Author
    9. name
      Dezube BJ
      type
      Author
    bibliography ids
    1. nci-bib-44245430319ee1f8fdabd880
    book metadata
    content sha256
    09963bbc98a22a8bec0568107b93e6baf6d1344d424a40f1b03728207a9bfffc
    document type
    citation
    dois
    1. 10.1200/JCO.1998.16.2.683
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9469358
    immutable id
    pubmed:9469358@09963bbc98a22a8bec0568107b93e6baf6d1344d424a40f1b03728207a9bfffc
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    2
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    683-91
    volume
    16
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9469358
      provenance
      batch id
      fff67794fd83a61706ce
      provider
      NCBI PubMed ESummary
      record sha256
      dddd103b2deb5fbbc366bd13eed3b7297d5831dcc6260b7b96e1e4d12e29e0d7
      response sha256
      bedc2583321e1fd4327b987cd9a11c78de8d225d1f0ce57e6a3d1d51b5f54126
      retrieved at
      2026-09-09T23:45:29.081942+00:00
      publication date
      display
      1998 Feb
      precision
      month
      year
      1998
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Comparative Study
      4. Journal Article
      5. Multicenter Study
      6. Randomized Controlled Trial
      7. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9469358/
      title
      Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

      Preserved source evidence · Not medical advice